Characteristic kidney pathology, gene abnormality and treatments in LCAT deficiency
Lecithin:cholesterol acyltransferase (LCAT) is a key enzyme involved in reverse cholesterol transport from the peripheral tissues to the liver. LCAT deficiency, in which this enzyme is congenitally absent, is a genetic disease that impairs the esterification of free cholesterol in the plasma, leading to accumulation of phospholipids, including lecithin, in the organs of the body; the clinical manifestations include corneal opacities, normochromic anemia, renal disorder, etc. The prognosis is determined by the degree of renal dysfunction, and renal biopsy specimens reveal characteristic light- and electron-microscopic findings. The disease, transmitted by autosomal recessive inheritance, is extremely rare. There have only been 88 gene mutations of the LCAT gene reported around the world, and 13 of them are from Japan. One of the characteristics of LCAT deficiency is the strong correlations among the patterns, extent and phenotypes of these gene mutations.
KeywordsLCAT deficiency Kidney pathology Gene abnormality Treatments
- 1.Glomset JA, Norum KR. The metabolic role of lecithin: cholesterol acyltransferase: perspectives form pathology. Adv Lipid Res. 1973;11:1–65.Google Scholar
- 6.Human Gene Mutation Database (2010). (http://www.biobase-international.com/product/hgmd).
- 7.Maruyama T, Yamashita S, Matsuzawa Y, Bujo H, Takahashi K, Saito Y, Ishibashi S, Ohashi K, Shionoiri F, Gotoda T, Yamada N, Kita T. Mutation in Japanese subjects with primary hyperlipidemia (Results from the research committee of the Ministry of Health and Welfare of Japan since 1996. J Atheroscler Thromb. 2004;11:131–45.PubMedCrossRefGoogle Scholar
- 16.Appel GB, Radhakrishnan J, Vilette D. Lecithin-Cholesterol Acyltransferase Dificiency. Brenner and Rector’s The Kidney, 9th Ed. vol 1; 2012. p. 1245–6.Google Scholar
- 17.Jennette JC, Olson JL, Schwartz MM, Silva FG. Lipid disorders familial lecithin-cholesterol acyl transferase deficiency. heptinstall’s pathology of the kidney 6th Ed. vol 1; 2006. p. 1200–3.Google Scholar
- 23.Bujo H, Kusunoki J, Ogasawara M, Yamamoto T, Ohta Y, Shimada T, Saito Y, Yoshida S. Molecular defect in familial lecithin:cholesterol acyltransferase (LCAT) deficiency: a single nucleotide insertion in LCAT gene causes a complete deficient type of the disease. Biochem Biophys Res Commun. 1991;181:933–40.PubMedCrossRefGoogle Scholar
- 27.Aranda P, Valdivielso P, Pisciotta L, Garcia I, Garcã A-Arias C, Bertolini S, Martã N-Reyes G, Gonzã Lez-Santos, Calandra S. Therapeutic management of a new case of LCAT deficiency with a multifactorial long-term approach based on high doses of angiotensin II receptor blockers (ARBs). Clin Nephrol. 2008;69:213–8.PubMedCrossRefGoogle Scholar